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Evolution of Diagnostic Methods 




In clinical, research, and public health laboratories, many diagnostic methods 
are used to detect the coronavirus. Some tests directly detect infection by detecting 
viral RNA, while others detect the disease indirectly by detecting host antibod-
ies. Several studies on SARS-CoV-2 diagnostic methods have found varying 
throughput, batching capacity, infrastructure requirements, analytical efficiency, 
and turnaround times ranging from minutes to hours. Serosurvey studies have 
been conducted for antibodies to understand, model, and forecast the prevalence 
of the disease in an area. While on the research and predictive modeling side, 
sampling and analysis of sewage have been conducted to determine the number of 
RNA copies and hence the prevalence. Certain studies indicate usefulness of GIS 
(Geographic Information System) for understanding the pervasiveness of COVID-
19 in an area as well. The current chapter deals with the evolution of diagnostic 
techniques for COVID-19 and discusses use of specific techniques and appropriate-
ness in certain specified conditions. It also focuses on understanding the methods 
used for assessing the prevalence of COVID-19 in a particular region to extract miti-
gative strategies from it, either by prediction or management of the affected area.
Keywords: COVID-19, SARS-CoV-2, RT-PCR, GIS, wastewater treatment, 
biosensors, CRISPR
1. Introduction
Different testing methods are used in clinical, academic, and public health labo-
ratories to diagnose the coronavirus. These methods have different output, batching 
capacity, analytical result performance, specific requirement of infrastructure 
setting and worktime. Some tests, such as direct tests, detect viral RNA directly to 
determine infection, while indirect tests diagnose infection indirectly by measuring 
host antibodies. The methods that are used for the diagnosis of coronavirus should 
have enough accuracy and sensitivity to make proper clinical decisions quickly in 
this pandemic so that the spread of the virus can be controlled [1–3]. A number 
of experiments were carried out to determine economic loss as well as the urban 
microclimate [4, 5].
A number of methods that are used for diagnosis have been given an approval 
from World Health Organization (WHO) and by the US Food and Drug 
Administration (FDA), while due to the rapid spread of the virus, the Emergency 
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Use Authorization (EUA) has granted conditional approval to several new methods 
[1–6]. Several studies on sewage sampling and analysis as well as use of Geographic 
Information System (GIS) have also been conducted to understand the cause of 
epidemics, its spread pattern and to predict the occurrence of disease in an area. 
GIS acts as a useful tool in easing the fight against coronavirus with its advanced 
features such as mapping, location intelligence and spatial analysis providing a way 
to the government or public authorities in the determination of active COVID - 19 
cases, recoveries, fatalities and even creating containment/hotspots zones [7]. On 
the other hand the surveillance of wastewater with the help of water based epide-
miology [WBE] detects the RNA of the viral genome of SARS-CoV-2 enabling the 
further mitigation of the virus. The samples of the wastewater are collected and 
tested from the sewer lines indicating the more accurate location of coronavirus 
outbreak leading to the reorganization of area of concern [8]. It was also discov-
ered that air plays a significant role in the spread of the SARS-CoV-2 virus, as it is 
transmitted through air [9].
Apart from the equipment and the method used, the result also depends on 
collection of sample, use of reagents, and probability of cross-contamination and 
storage requirements for samples/reagents. While selecting any reliable and fast 
diagnostic method all these factors should be considered so that a proper decision 
and immediate action to public health can be made. This chapter focuses on the 
various types of COVID-19 diagnosis methods presently in use in a comprehensive 
manner and also the working efficiency of the different methods by checking vari-
ous parameters such as sensitivity, time of detection, specificity etc. in comparison 
to other methods. An attempt has been made to discuss the prediction methods 
used for COVID-19 prevalence detection and analysis. The broad areas focused in 
the chapter includes diagnosis of COVID-19 and surveillance system for disease 
prevalence.
2. Diagnosis of COVID-19
Coronavirus is detected by reviewing the affected person’s medical history, 
beginning with the point of contact and progressing through the findings of certain 
clinical examinations. Various respiratory problems and symptoms like pneumonia 
also comes under COVID-19 symptoms. Diagnosis methods like reverse transcrip-
tion – polymerase chain reaction (RT-PCR) are being used now a days. Day by day 
with passing time many more methods are being developed but are pending for the 
approval from the regulatory authorities. The diagnostic methods that are studied 
and discussed in the chapter are shown in Figure 1 and Table 1. These methods 
have been discussed in detail in the subsequent sections.
2.1 Reverse transcription – polymerase chain reaction (RT-PCR)
RT–PCR is currently the most commonly used laboratory methods for the 
detection of SARS-CoV-2. This method uses a technique derived from nuclear 
material to determine the existence of unique genetic material in any pathogen, 
including viruses. It’s also being used to identify other diseases including the Ebola 
virus and the Zika virus. This method necessitates the collection of samples from 
body parts where the virus has accumulated, such as the nose or the throat [10]. To 
extract only the RNA present in the sample, it is treated with different chemicals 
to remove substances such as proteins and fats. This RNA is a combination of the 
person’s genetic material and, if present, the virus’s RNA. The procedure continues 
with the technique of merging reverse transcription of RNA into complementary 
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DNA or cDNA, followed by polymerase chain reaction amplification of particular 
DNA (PCR) [11]. According to various studies, there are several advantages of the 
real time RT-PCR such as it is very highly sensitive, needs only a small amount of 
DNA and gives fast results in a duration of three hours as compared to other meth-
ods, which usually consumes six to eight hours [12, 13]. It is also the most precise 
method and gives accurate results after detection. This method, however, does not 
detect past infection, necessitating the use of other methods to detect, monitor, and 
study past infections, especially those that may have evolved and spread without 
causing symptoms. Other disadvantages includes its higher cost due to use of 
expensive apparatus, which makes it quite uneconomical [14, 15]. The flow process 
for virus detection using RT-PCR technique is given in Figure 2.
2.2 Next generation sequencing (NGS)
The method of determining the nucleic acid sequence – the order of nucleotides 
in DNA, i.e. the order of the four bases: adenine, guanine, cytosine, and thymine – 
is known as DNA sequencing [16]. There are several DNA sequencing approaches, 
one of which is NGS, also known as High-throughput sequencing (HTS). By NGS, 
in a single experiment it is possible to determine the genomic sequencing of more 
than 1 million base pairs and hence this method is used for diagnosing inheritable 
diseases, cancer, and infectious diseases [17, 18]. NGS technology employs array-
based sequencing, which utilitizes Sanger sequencing techniques to process millions 
of reactions in parallel, resulting in extremely high speed and throughput at a lower 
cost [19]. The first step in NGS is library preparation, which involves randomly 
fragmenting DNA to build libraries, followed by ligation with custom linkers. 
Amplification is the second step, in which the library is amplified using clonal 
amplification methods, and PCR Sequencing is the third step, in which DNA is 
sequenced by using one of the several strategies. This method for diagnosis is speci-
fied as it provides all related information and is also highly sensitive. It is helpful in 
Figure 1. 
















Working principle Time required Cost of treatment 
per individual
Advantages Disadvantages References
RT-PCR Reverse transcription & 
amplification
3–4 hrs Rs 2000 - Rs 2500 Cost effective & rapid small 
amount of DNA is required





Capillary electrophoresis 1–2 days Rs. 25000 – Rs 
.55000
Highly sensitive, gives quick 
and accurate results and is more 
reliable.





Chest images by X-Ray 
technology
1 hr RS 5700 Rapid identification and higher 
sensitivity.
Cannot accurately 
distinguish between COVID 







Primer detection and 
amplification by reverse 
transcription
30 min Rs. 200 Very cheap and reliable method, 
gives quicker analysis.
Requires complex 
equipment and shows less 
sensitivity
[3, 4, 53, 54]
Rapid Antigen based 
testing
Detection of presence of 
vital proteins (antigens)
15–30 min Rs.600-Rs.500 Very affordable. High testing 
speed and sensitivity
May lead to false negatives 





Rapid POC CE-IVD 15–30 min — Even a fully recovered person can 
help other patient free on cost 
in combating virus and hence 
supporting humanity.
Depends on the time and 
speed of the development of 
antibodies.
Positive results of test take 
6–7 days.
[36, 37]
CRISPR Gene Editing technology 10–5 min Rs.500 Cheap, easily accessible, high 
speed and aacurate and fast 
results just within 45 minutes.
Risk of toxicity. [40, 41]
Biosensors Mechanism of Receptor 
and transducer
60–45 min — User friendly and detects virus in 
mass population rapidly
Less accuracy [43, 44]
Table 1. 
Different methods for diagnosis of COVID-19.
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identifying secondary infections and has potential tracing. However it is expensive 
and requires sophisticated laboratory for conducting test.
2.3 Computed tomography (CT)
A computed tomography scan (CT scan) is a medical imaging technique that 
uses computer-processed combinations of several X-ray measurements taken from 
various angles to create cross-sectional images of the body, enabling the patient to 
see inside the body without cutting it open. COVID-19 is a respiratory disease that 
affects the parenchyma, but several studies claim that extreme cases are linked to a 
pro-inflammatory cytokine storm that leads to systemic inflammation and sepsis, 
as well as involvement in other organs such as the cardiovascular system [20]. An 
integrated Computed Tomography (CT) method may provide useful information 
on the diagnosis of COVID-19 patients in such circumstances. The expression of 
acute interstitial lung damage and the subsequent parenchymal changes induced 
by the cytokine storm triggered by the virus’s internalization into the pneumocytes 
are normal CT findings in patients with COVID-19 [21–23]. During the early 
stages of the pandemic, CT was commonly used in China to diagnose COVID-19. 
Although the National Health Commission of China’s current recommendations 
do not include imaging findings in diagnosis of this disease [24]. Furthermore, the 
American College of Radiology does not consider using a chest CT scan to test for 
COVID-19 pneumonia as a first-line imaging modality. Patients with symptoms like 
pulmonary embolism, empyema, or co-infection should get a CT scan, according to 
the recommendations. Using RT-PCR as a reference standard, several studies have 
demonstrated the sensitivity of CT. CT scan is being appreciated for its accuracy 
in results however; extreme precaution must be taken with respect to COVID-19 
disease because of a negative CT scan. When compared to RT-PCR, a CT scan of the 
chest has a sensitivity of 89% and a Likelihood Ratio (LR) of 0.16, according to a 
study. With an LR+ of 2.81, specificity was moderate (68%) [25].
2.4 Loop mediated isothermal amplification (LAMP)
For the diagnosis of SARS–CoV-2, isothermal polymerase chain reactions 
methods such as loop-mediated isothermal amplification (LAMP) are supposedly 
Figure 2. 
Working process of RT-PCR method.
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a replacement for the RT-PCR process [26]. As compared to RT - PCR, LAMP is a 
powerful nucleic acid amplification method that works under isothermal tempera-
ture conditions and thus does not involve frequent temperature changes. To allow 
rapid amplification, this method involves designing assay primers and using a 
strand-displacing polymerase. LAMP reaction mix includes six primers that target 
eight different areas of the bacterial or viral genome. Currently RT-LAMP technique 
is being used for detecting COVID-19. RT- LAMP is a mechanism for auto cycling 
strand displacement DNA synthesis in which a polymerase uses one pair of inner 
and one pair of outer primers to carry out a reaction with high strand displace-
ment operation. This method uses six independent sequences at the start and four 
independent sequences at the end to identify the target sequences. Primer identi-
fication of the target genome leads to a strong colorimetric reaction. The nucleic 
acid sample, 4 (or 6) specially formulated primers, and the best DNA polymerase 
are all incubated in the same test tube at 60 to 65 degrees Celsius, depending on the 
optimum LAMP temperature [27]. The ORF1ab gene, S gene, and N gene are among 
the main areas of coronavirus genomes where the primers are built for this process. 
ORF1ab is responsible for viral genome replication, while the S gene is required 
for coronavirus to bind to human ACE2 protein, and the N gene is a nucleocapsid 
protein found in many coronaviruses [28]. RT- LAMP completes the detection just 
within 25–30 minutes hence making it more reliable & suitable as compared to the 
RT-PCR for monitoring. Although it projects lot of gains, it has limitations such 
as slightly lower sensitivity of RT-LAMP as compared to RT - PCR. Some ongoing 
research recommended that the addition of guanidine could improve the sensitivity 
of detection with RT-LAMP [29]. RT-LAMP has a sensitivity of 75% as compared 
to RT-PCR, but unlike RT-PCR, it does not produce false-positive results, and when 
the results of RT-PCR and RT-LAMP are combined, diagnostic sensitivity increases 
to 92–100% [30], proving it to be a good technique.
2.5 Rapid diagnostic test based on detection of antigens
Since antigen tests are simple to perform, they are in high demand for COVID-
19 diagnosis. For the evaluation of serious infections in samples, the novel rapid 
antigen detection test (RADT) is used. This test looks for and detects antigens 
generated by the SARS-CoV-2 virus in a sample taken from a person’s respiratory 
tract [31, 32]. If adequate concentrations of target antigens are present in the 
sample, it will merge with particular antibodies fixed on a paper strip attached to a 
plastic casing within 30 minutes, using either visual or visible. Since the antigens 
found in the body are only released while the virus is actively replicating, such tests 
are the best used to detect acute or the early infection. This test depends on factors 
such as quantity and quality of virus collected from the person’s body, duration 
from onset of one’s illness, reagent formulation in a test kit. The test is cost effective, 
determines results in minutes and reveal an actively infection. They are already 
being used for influenza, HIV, tuberculosis (TB) and other infectious diseases 
[33, 34]. Due to the limited data availability for this test currently WHO does not 
recommend the antigen test keeping in mind the patient’s health but encourages 
more research under this field.
2.6 Rapid diagnostics tests based on detection of antibodies
This is the most common type of test for the diagnosis for COVID-19. The work-
ing principle of this test includes the detection antibodies present in blood sample 
of people infected from COVID-19. It detects two types of antibodies isotopes 
namely: IgG and IgM [34]. The development of antibodies and their responses 
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varies from person to person accordingly. Some studies show that antibodies 
response is detected only in 2nd week from the development of COVID-19 symp-
toms [35] i.e. during the recovery phase. A COVID-19 antibody-based tests can 
cross-react with other pathogens, including other human coronaviruses [35, 36], 
resulting in false-positive results. The timing and type of antibody testing deter-
mines accuracy. One of the benefits of this testing is that people who have recovered 
from COVID-19 will donate their plasma, which is then used to cure those who have 
serious disease and improve their capacity to combat the virus. These tests can be 
conducted on blood, serum, or plasma samples, with results available in 30 minutes 
and a positive result after 7–10 days of infection [36, 37].
2.7 CRISPR/Cas
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a 
rapid approach for diagnosing COVID-19, was recently suggested by scientists 
and researchers. CRISPR is a family of DNA sequences found in the genomes of 
prokaryotic organisms including bacteria and archaea that function as an immune 
system against foreign elements in archaea and bacteria. CRISPR is also used poten-
tially to treat genetic diseases and cancer [38]. This approach employs gene-editing 
technology, which allows for the detection of the coronavirus in just 5 minutes and 
the delivery of results in just 45 minutes, attracting a lot of interest. The COVID-
19 CRISPR test identifies a 20-base RNA sequence by using a “guide” RNA that is 
complementary to the target RNA sequence and binds to it in the solution. When 
guide RNA binds to target RNA, CRISPR tools Cas 13 “Scissors” enzyme activates 
and cuts apart any nearby single – stranded RNA. Such cuts release a fluorescent 
particle separately in the test solution. The sample is then hit with a laser light 
and the released fluorescent particle if lighted up indicating the presence of coro-
navirus. This method for the diagnosis of coronavirus is currently being used by 
Sherlock Biosciences, US and in India by Tata group under the brand name ‘Feluda’. 
CRISPR does not require specialized or expensive laboratory apparatus and hence 
can be perfectly deployed in doctor’s office, schools and office buildings. Other 
advantages of this method include its great programmability and its speed [39]. 
However, there are certain drawbacks to the CRISPR - Cas9 diagnostic technique, 
such as off-target effects and unexpected mutations, which are a major worry, par-
ticularly when it is used for both therapeutic and diagnostic purposes. Because Cas 
proteins are obtained from prokaryotic origins, in vivo application of these proteins 
causes toxic effects in the human cells that contain them, as well as immunological 
activation and the creation of cas protein specific antibodies, which could obstruct 
the therapeutic application of CRISPR technology [40, 41].
2.8 Biosensors
Biosensors are new emerging technology for the rapid detection and diagnosis 
of mass population infected with SARS-CoV-2. Biosensors are made up of chemi-
cal or biological receptors that interact with the target analyte directly, as well 
as a transducer that translates the detection process into a quantitative signal. 
Biosensors target biological recognition of molecules such as enzymes, nucleic acids 
or antibodies and contain transducer and a detector detects the interaction with the 
analyte and generates an output digitally. Biosensors are classified into four types 
such as electrochemical biosensors, piezoelectric biosensors, thermal biosensors 
and optical biosensors. In the recent trend of biosensor, RT-LAMP is mediated with 
Nano particles biosensors (NBS). According to studies, with biosensors, RT-LAMP 
is less error prone and achieves higher specificity and low false positive result [42]. 
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CRISPR gene editing technology was recently updated as a biological sensor by 
combining a CRISPR chip with a Field of Effect Transistor (FET) to diagnose 
COVID-19 in under 40 minutes [40]. Plasmonic Photothermal (PPT) and local-
ized surface plasmon resonance (LSPR), a dual-function plasmonic biosensor, 
were designed for the ongoing detection of COVID-19 pandemic. For a few covid 
sequences, the LSPR biosensor has a higher sensitivity, with a detection maximum 
of up to 0.22 ppm concentration [43]. Biosensors are mostly designed on the basis 
of surface nucleoproteins. Piezoelectric immune-sensor and thermal biosensor 
are also being used for detecting the SARS-CoV-2 virus. The electrochemical 
paper-based biosensor uses the high –ultra charge transfer efficiency AuNPs with 
magnetic NPs (Fe204). These biosensors are biodegradable, sensitive, simple and 
economical [44].
In addition to the methods used to diagnose COVID – 19, some innovative tech-
niques are being used to forecast the source and frequency of the virus’s spread so 
that it can be monitored by implementing some mitigation steps, based on various 
surveys and studies.
3. Surveillance of COVID-19
3.1 Geographical information system (GIS) based study
GIS is an information system for capturing, gathering, analyzing and manag-
ing data into visual form. GIS has brought a new trend of revolution in the field 
of health and therefore it can be encouraged to be used as a support tool for 
the tracking of COVID -19 cases during this global pandemic [45]. The world 
health organization even uses the GIS technology to map and update number of 
COVID - 19 cases and also lists the deaths occurring all over the world on their 
dashboard regularly. The spatiotemporal algorithms present in GIS are helpful 
in identifying the COVID -19 outbreak faster. The algorithms therein are useful 
in assessing and recording the appropriate number of people infected with the 
virus. GIS assisted with remote sensing provides the real time aerial and satellite 
photographs which leads to the evaluation of the disease growth and fluctuations 
all over the world or in a particular area [46]. The above information captured 
through GIS is useful in analyzing and locating the area which is worst affected 
and the areas under risk zone where the virus is likely to spread rapidly in future. 
Through GIS technique we can became aware of the spread of COVID 19 in 
advance and hence can take strict decisive actions in areas facing serious COVID 
circumstances [47]. The ways in which GIS tools can be helpful are summarized 
in Figure 3.
The other ways in which GIS technology can be used for limiting the disease 
spread includes contact tracing, selection of sites for emergency treatment units and 
digital mapping that shows location and time-sensitive functions directly related 
to a spread of virus and hence alert the officials to cancel the particular public 
event, minimizing the number of persons affected. Web maps are also useful in 
solving the problem of acute supply of medical appliances signaling the distributors 
[48]. Researches have used GIS and modeling techniques to understand overlap of 
environmental parameters such as air pollution, microclimate, and impact on SDGs 
with COVID-19 prevalence [49]. The parametric and probabilistic modeling along 
with statistical tools available with GIS have also been used to understand disease 
prevalence and management in countries [50]. Currently many mobile/android 
applications are based on GIS technology such as Aarogyasetu (India), COVID-19 
symptom trackers, etc. launched by many countries, which are used for contact 
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tracing [51]. These applications are cost efficient, present accurate data and thus are 
more reliable.
3.2 Wastewater surveillance system
There is growing proof of presence of SARS-CoV-2 in the sewage [51, 52]. 
Multiple focused researches have been carried out to analyze the presence of virus 
in wastewater [53]. Many studies have proved wastewater based epidemiology as 
an eligible and effective tracking tool in detecting SARS-CoV-2 genome at ambient 
temperature of 45°C giving us a better understanding of the present spreading of 
the global pandemic. This has led to growing concern in public health authorities 
for the essential need of the analysis of sewage samples from the sewage treatment 
plants for computing the presence of viral genome of SARS-CoV-2. While this is a 
Figure 3. 
Role of GIS in disease prevalence mapping, analysis and management.
Figure 4. 
Analysis of disease prevalence using wastewater samples.
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grave concern, it has also presented as an opportunity for the utilization of water-
based surveillance system for monitoring and investigating the presence of virus 
in sewage. The detection of virus in the wastewater samples has created a further 
possibility that the wastewater containing the virus can also release the same virus 
into other water bodies such as sea, groundwater, etc. The samples can be collected 
from drains and sewage treatment plants to understand the load of virus being shed 
by a particular community [54, 55]. The samples once taken, can be analyzed for 
load of virus present in it, followed by data analytics to back calculate the disease 
prevalence in an area. Figure 4 represent the analysis of wastewater samples for 
COVID-19 prevalence.
Through wastewater sample analysis, the disease prevalence calculation can 
serve as an early warning for spreading pandemic in an area. This may give the 
authorities to act in timely manner for management of proliferation of COVID-19 
in the area considered for analysis. Wastewater surveillance comes along with many 
benefits such as it is an economical method and also acts as a early warning tool 
signaling the transmission of the disease by neglecting the other epidemiological 
indicators and gives successful evidences and results [55].
4. Conclusion
Taking into account the present situation of a pandemic it becomes extremely 
essential to develop a fast, effective, risk-free, and reliable method for diagnosis 
of COVID-19. There are several diagnostic methods available today for detecting 
the virus but each method has its pros and cons. Attributes such as accuracy level, 
complexity of instrumentation, the need for sample preparation & purification, 
operational and capital cost, time, geo-spatial availability, high technical skills and 
so on are to be considered before finalizing the best method of testing. The use of 
RT-PCR diagnosis for the virus is common and widely used everywhere due to its 
higher accuracy, sensitivity and reliability but due to its expensiveness, it cannot be 
afforded by lower incomes countries and is also a not suitable method for screening 
a large population at a time. Many new diagnostic methods such as RT-LAMP and 
CRISPR based technologies are also emerging which provide rapid, user-friendly, 
higher specificity & sensitivity, efficient and low-cost diagnosis of SARS-CoV-2 and 
can be deployed on the airports, office buildings, schools, etc. due to their nature of 
the simple operation, however, CRISPR has a little risk of contamination associated 
with it. Rapid serological methods based on antibodies/antigens are proving to be 
faster tests but not always give faster results and are not recommended because of 
their limited research. Currently to overcome the COVID-19 pandemic develop-
ing rapid, reliable, and novel biosensors for the detection of the virus is of much 
interest and will prove to be paradigm altering in surveillance, once perfected. 
The development of new SARS-CoV-2 biosensors is focused on the detection 
of biomarkers from human hosts, rather than antibodies or immunoglobulins. 
Developing sensitive, space-friendly, and portable biosensors can prove beneficial 
for the quick diagnosis of the virus.
With diagnosis, another important aspect is the assessment of disease preva-
lence in an area. The infection spread of SARS-CoV-2 is rapid and mostly happens 
through air, hence checking the prevalence of disease only after appearance of 
symptoms may not help in controlling the spread of virus. For that, advanced 
tools such as GIS or modeling techniques have to be used which can act as an 
early warning system. The GIS technology enables the local authorities as well as 
general public to recognize particular hotspots and take preventive measures in 
the right time. GIS based platforms and models can help in management of spread 
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of virus through visualization and data analytics. Many tools and techniques use 
GIS for contact tracing and identification of containment sites. Another way the 
early warning system can be established is through wastewater sample analysis for 
analysis of virus. The time lag functions can be developed for various areas through 
thorough sampling and analysis of wastewater and disease prevalence in the area 
in order to understand the disease progression and forecast in that area. While this 
chapter discusses major techniques used for diagnosis and prevalence of COVID-19 
among the population, the researchers are continuously working on finding better 
methods. The chapter comprehensively covers the methods being used currently 
for targeting and managing the spread of this virus and should helpful in getting an 
overview related to the tools and techniques being used for the assessment.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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